$495 Million Worldwide Drug and Gene Delivery Devices Industry to 2027 - Impact Analysis of COVID-19 - ResearchAndMarkets.com

The "Drug and Gene Delivery Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Drug and Gene Delivery Devices estimated at US$495 Billion in the year 2020, is projected to reach a revised size of US$767.3 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027.

Oral, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$366.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Inhalation segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $134 Billion, While China is Forecast to Grow at 9.8% CAGR

The Drug and Gene Delivery Devices market in the U.S. is estimated at US$134 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$165 Billion by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Transdermal Segment to Record 6.8% CAGR

In the global Transdermal segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$37.2 Billion in the year 2020 will reach a projected size of US$57 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$104.4 Billion by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.

Select Competitors (Total 36 Featured):

• Bayer AG
• Becton, Dickinson and Company
• Dickinson
• Epeius Biotechnologies
• F. Hoffmann-La Roche Ltd.
• Human Stem Cells Institute
• Johnson and Johnson
• Novartis AG
• Pfizer, Inc.
• Shanghai Sunway Biotech Co., Ltd.
• SiBiono GeneTech Co
• Uniqure N.V

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• UNITED STATES
• CANADA
• JAPAN
• CHINA
• EUROPE
• FRANCE
• GERMANY
• ITALY
• UNITED KINGDOM
• SPAIN
• RUSSIA
• REST OF EUROPE
• ASIA-PACIFIC
• AUSTRALIA
• INDIA
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LATIN AMERICA
• ARGENTINA
• BRAZIL
• MEXICO
• REST OF LATIN AMERICA
• MIDDLE EAST
• IRAN
• ISRAEL
• SAUDI ARABIA
• UNITED ARAB EMIRATES
• REST OF MIDDLE EAST
• AFRICA

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/9pb2d0

View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005563/en/